About Cytochrome P450 3A5
Cytochrome P450 3A5 (CYP3A5) is a protein
from Homo sapiens identified by UniProt accession
P20815, 502 residues long.
MolForge cross-references it against 0 known binders and
315 disease associations.
Target properties
| Protein name | Cytochrome P450 3A5 |
| UniProt accession | P20815 |
| Gene | CYP3A5 |
| Organism | Homo sapiens |
| Length | 502 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Approved drugs hitting this target (8)
DrugCentral-linked approved drugs that act on this protein.
Disease associations (315)
Diseases linked to this target (Open Targets).
- HIV infection · score 0.61
- HIV-1 infection · score 0.60
- COVID-19 · score 0.59
- AIDS · score 0.58
- chronic hepatitis C virus infection · score 0.57
- infection · score 0.56
- hepatitis C virus infection · score 0.55
- HIV-Associated Lipodystrophy Syndrome · score 0.46
- coronavirus infectious disease · score 0.43
- cancer · score 0.41
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P20815-F1 | alphafold | PREDICTED | 93.41 | — |
Amino-acid sequence (502 residues)
MDLIPNLAVE TWLLLAVSLV LLYLYGTRTH GLFKRLGIPG PTPLPLLGNV LSYRQGLWKF DTECYKKYGK MWGTYEGQLP VLAITDPDVI RTVLVKECYS VFTNRRSLGP VGFMKSAISL AEDEEWKRIR SLLSPTFTSG KLKEMFPIIA QYGDVLVRNL RREAEKGKPV TLKDIFGAYS MDVITGTSFG VNIDSLNNPQ DPFVESTKKF LKFGFLDPLF LSIILFPFLT PVFEALNVSL FPKDTINFLS KSVNRMKKSR LNDKQKHRLD FLQLMIDSQN SKETESHKAL SDLELAAQSI IFIFAGYETT SSVLSFTLYE LATHPDVQQK LQKEIDAVLP NKAPPTYDAV VQMEYLDMVV NETLRLFPVA IRLERTCKKD VEINGVFIPK GSMVVIPTYA LHHDPKYWTE PEEFRPERFS KKKDSIDPYI YTPFGTGPRN CIGMRFALMN MKLALIRVLQ NFSFKPCKET QIPLKLDTQG LLQPEKPIVL KVDSRDGTLS GE
Explore Cytochrome P450 3A5 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets